0000905718-19-000315.txt : 20190402 0000905718-19-000315.hdr.sgml : 20190402 20190402165116 ACCESSION NUMBER: 0000905718-19-000315 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190402 DATE AS OF CHANGE: 20190402 EFFECTIVENESS DATE: 20190402 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CytoDyn Inc. CENTRAL INDEX KEY: 0001175680 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 753056237 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-336290 FILM NUMBER: 19725767 BUSINESS ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 BUSINESS PHONE: 360-980-8524 MAIL ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 FORMER COMPANY: FORMER CONFORMED NAME: CYTODYN INC DATE OF NAME CHANGE: 20031114 FORMER COMPANY: FORMER CONFORMED NAME: REXRAY CORP DATE OF NAME CHANGE: 20020617 D 1 primary_doc.xml X0708 D LIVE 0001175680 CytoDyn Inc. 1111 MAIN STREET, SUITE 660 VANCOUVER WA WASHINGTON 98660 360-980-8524 DELAWARE RexRay Corporation CYTODYN INC REXRAY CORP Corporation true Nader Z. Pourhassan c/o CytoDyn Inc. 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Executive Officer Director Michael D. Mulholland c/o CytoDyn Inc. 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Executive Officer Jordan G. Naydenov c/o CytoDyn Inc. 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Director Richard G. Pestell c/o CytoDyn Inc. 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Executive Officer Director Gregory A. Gould c/o CytoDyn Inc. 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Director Michael A. Klump c/o CytoDyn Inc. 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Director Carl C. Dockery c/o CytoDyn Inc. 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Director Scott A. Kelly c/o CytoDyn Inc. 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Director David F. Welch c/o CytoDyn Inc. 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Director Biotechnology Decline to Disclose 06b false 2019-03-20 false true true true true Convertible Preferred Stock with Warrants false 0 Paulson Investment Company, LLC 5670 None None 2141 W. NORTH AVE. 2ND FLOOR CHICAGO IL ILLINOIS 60647 All States false 5000000 3246000 1754000 false 53 250000 true 0 Assumes maximum commissions earned. 0 true Some of the proceeds may be used for general working capital purposes which may include the payment of salaries and other fees to those listed in Item 3. false CytoDyn Inc. /s/ Michael D. Mulholland Michael D. Mulholland Chief Financial Officer 2019-04-02